Successful E-Beam sterilization begins long before routine irradiation processing. Decisions made during product development can have a significant impact on the sterilization process and its successful implementation. Material selection, product and package design, sterilization dose, and validation strategy all influence product performance, validation, processing efficiency, project timelines, and cost. Considering these factors early and validating the sterilization process in accordance with ISO 11137 helps establish a robust process in which the required absorbed dose is consistently delivered while maintaining product quality.
This article outlines five important considerations to keep in mind when planning an E-Beam sterilization project.
1. Evaluate Material Compatibility
Electron beam (E-Beam) sterilization can be used with a wide range of materials, including polymers, elastomers, adhesives, thermosets, metals, glass, and cellulosic materials. Among these, polymers are the most common materials used in medical devices.
Ionizing radiation can alter polymers through chain scission or cross-linking, resulting in changes to molecular weight, mechanical properties, color, and overall product performance. The extent of these changes depends on the polymer chemistry, formulation, radiation dose, and environmental conditions. Material compatibility should be demonstrated at the intended sterilization dose and maintained throughout the claimed shelf life.
Key considerations:
- Select materials that are compatible with ionizing radiation.
- Favor radiation-resistant polymers when appropriate for the application.
- Consider the use of antioxidants or stabilizers to minimize oxidative degradation.
- Recognize that amorphous polymers generally exhibit greater radiation tolerance than highly crystalline polymers.
- Evaluate functional performance, material compatibility, and accelerated and/or real-time aging at the intended sterilization dose.
For a quick overview of unsuitable polymers, please see our LinkedIn post from our series, Radiation Sterilization: The 5 Most Common Faults and How to Avoid Them.
2. Design for Radiation Processing
Product and packaging design directly affect absorbed dose distribution, dose uniformity, and material response during irradiation. These factors should be considered early to ensure the product can be effectively sterilized while maintaining functionality and package integrity. Designing for radiation processing also helps improve process efficiency and supports successful validation.
Key considerations:
- Minimize sharp corners, abrupt thickness transitions, and significant variations in material thickness.
- Design products and packaging to achieve uniform product density and consistent absorbed dose distribution.
- Configure packaging with uniform product layers and consistent loading patterns while minimizing void spaces and excessive product overlap.
- Evaluate both low- and high-density product configurations and identify the worst-case irradiation configuration for validation.
3. Establish the Sterilization Dose
Determine the sterilization dose required to achieve the specified Sterility Assurance Level (SAL) using an ISO 11137 dose establishment method. Validation activities include bioburden characterization, dose verification, and sterility testing, as applicable to the selected method.
Key considerations:
- Bioburden characterization
- Sterility testing
- Sterility Assurance Level (SAL)
- Dose verification methodology
For more information about ISO 11137 standards, please refer to BGS Beta Gamma Service’s blog, ISO 11137: An Overview of the Procedural Standards, or our LinkedIn post, ISO 11137: A Process Standard Overview.
4. Define the Maximum Acceptable Dose
The maximum acceptable dose should be established by demonstrating that irradiated product continues to meet all functional, performance, safety, and package integrity requirements throughout its intended shelf life. Because radiation effects are cumulative, testing should be performed using product irradiated to the maximum cumulative dose.
Key considerations:
- Functional performance testing
- Mechanical and material compatibility testing
- Package integrity testing
- Maximum cumulative dose
- Real-time aging studies on product irradiated at the maximum acceptable dose to demonstrate continued functionality, package integrity, and usability throughout the claimed shelf life
5. Plan for Operational Success
Routine processing requirements should be incorporated early in product development to establish a robust, efficient, and reproducible sterilization process. Collaboration with the selected sterilization provider during product and packaging development helps optimize the processing configuration and supports consistent dose delivery during routine irradiation.
Key considerations:
- Work with the selected sterilizer to understand processing capabilities and establish the optimal product, packaging, and pallet configuration.
- Perform dose mapping to characterize absorbed dose distribution throughout the product load and identify locations receiving the minimum and maximum absorbed dose.
- Evaluate dose uniformity by determining the dose uniformity ratio (maximum absorbed dose ÷ minimum absorbed dose).
- Optimize product orientation, packaging configuration, and loading patterns to achieve acceptable dose uniformity.
- Define the final packaging configuration, including product orientation, number of units per package, shipping carton dimensions, and carton weight.
- Establish the final pallet configuration, including stacking pattern, pallet height, and pallet weight, to support consistent dose distribution and routine processing.
Designing for E-Beam sterilization is most effective when sterilization is treated as a product development consideration rather than a final manufacturing step. Evaluating material compatibility, optimizing product and packaging design, establishing appropriate sterilization parameters, and planning for routine processing early in development can help minimize risk, simplify validation, and support long-term product performance.
By following these best practices, and collaborating with an experienced sterilization partner throughout the process, medical device manufacturers can build a more efficient path from development to commercialization while maintaining the highest standards of quality and patient safety.
By Melissa Williams
Validation Technician, BGS US
References:
- ISO 11137-1, Sterilization of Health Care Products—Radiation—Part 1: Requirements for Development, Validation and Routine Control of a Sterilization Process for Medical Devices.
- ISO 11137-2, Sterilization of Health Care Products—Radiation—Part 2: Establishing the Sterilization Dose.
- ISO 11137-3, Sterilization of Health Care Products—Radiation—Part 3: Guidance on Dosimetric Aspects of Development, Validation and Routine Control.
- AAMI TIR17, Compatibility of Materials Subject to Sterilization.